Pier 88 Investment Partners LLC Neurocrine Biosciences Inc Transaction History
Pier 88 Investment Partners LLC
- $87 Million
- Q2 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 3,550 shares of NBIX stock, worth $397,174. This represents 0.56% of its overall portfolio holdings.
Number of Shares
3,550
Previous 1,450
144.83%
Holding current value
$397,174
Previous $199,000
145.23%
% of portfolio
0.56%
Previous 0.32%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.2MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.13 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$516 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$276 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$264 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...